Tag: Neurodegenerative disorder
Experimental Alzheimer’s drug receives FDA advisory panel’s approval: Progress is happeningSEO-friendly title: Alzheimer’s Drug...
An experimental Alzheimer's drug called donanemab received an endorsement from a U.S. Food and Drug Administration (FDA) advisory panel. The drug is intended to target symptoms of early Alzheimer's disease, such as mild cognitive...